Our long-term goal is to elucidate the principles by which cAMP controls cell development, proliferation and differentiation. cAMP regulates a striking number of physiologic processes, including intermediary metabolism, cellular proliferation, and neuronal signaling by altering basic patterns of gene expression via activation of cAMP response element (CRE)-directed transcription. The mechanism of the CRE-directed transcription in cell proliferation, however, is largely unexplored. Studies of the CRE-transcription in tumor cells compared to normal cells should contribute to the knowledge base for pharmaceutical design. To elucidate the role of the cAMP enhancer (CRE) in the control of cell proliferation, we used transcription factor-decoy oligonucleotide approach. Studies have shown that synthetic double- stranded phosphorothioate oligonucleotides with high affinity for a target transcription factor can be introduced into target cells as decoy cis-elements to bind the factor and alter gene transcription. Because the CRE cis-element TGACGTCA is palindromic, a synthetic single-stranded oligonucleotide composed of the CRE sequence self- hybridizes to form a duplex/hairpin. We investigated if synthetic single-stranded oligonucleotide of the CRE-palindromic and hairpin- forming oligonucleotides could penetrate cells, bind sequence-specific DNA-binding proteins, and interfere with the CRE-directed transcription in vivo. We found that a 24-mer CRE palindrome oligonucleotide (trioctamer of TGACGTCA) effectively competed with the cis-element for binding transcription factors and inhibited the gene transcription in a wide variety of cell types. Our finding that the CRE oligonucleotide inhibits the basal expression of RIa and Ca genes strongly indicates that the CRE oligonucleotide can indeed compete with the cis-CRE element in binding CREB. Because the CRE oligonucleotide can interfere with CREB binding to the CRE enhancer, it is expected that the oligonucleotide could produce a more profound effect on the mRNA reduction under cAMP-induced conditions. Thus, the CRE oligonucleotide can interfere with both the basal and cAMP-induced expression of the endogenous CRE-containing genes. CREB is known to associate with (e.g., heterodimerize) a variety of other transcription factors (e.g., members of the Jun/Fos family) and c-fos is cAMP-inducible. These findings demonstrate the cross-talk between CRE and AP-1. We found that the CRE- palindromic-oligonucleotide specifically interferes with both the CRE- and AP-1 directed transcription in vivo. Surprigingly, the CRE-decoy oligonucleotide restrained tumor cell proliferation without affecting the growth of non-cancerous cells. The dual blockage of two important signal transduction pathways, CRE-PKA and AP-1-PKC, could be causally related, at least in part, to the cancer cell specific growth inhibitory effect of the CRE decoy oligonucleotide.10268-03 LTIB is incorporated into this project. - Transcription, cyclic AMP response element, Transcription factor-decoy oligonucleotide, CRE and AP-1 Cross talk, cAMP and EGF Cross talk, Inhibition of tumor growth in vivo,

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC008281-17
Application #
6289194
Study Section
Special Emphasis Panel (LTIB)
Project Start
Project End
Budget Start
Budget End
Support Year
17
Fiscal Year
1999
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Nesterova, M; Johnson, N; Cheadle, C et al. (2006) Autoantibody biomarker opens a new gateway for cancer diagnosis. Biochim Biophys Acta 1762:398-403
Cho-Chung, Yoon S (2006) Autoantibody biomarkers in the detection of cancer. Biochim Biophys Acta 1762:587-91
Cho-Chung, Y S (2005) DNA drug design for cancer therapy. Curr Pharm Des 11:2811-23
Nesterova, Maria V; Cho-Chung, Yoon S (2004) Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis. Clin Cancer Res 10:4568-77
Cho-Chung, Yoon S (2004) Antisense protein kinase A RI alpha-induced tumor reversion: portrait of a microarray. Biochim Biophys Acta 1697:71-9
Kim, Young Hoon; Lim, Do Sun; Lee, Ji Hye et al. (2003) Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med 35:336-49
Cheadle, Chris; Cho-Chung, Yoon S; Becker, Kevin G et al. (2003) Application of z-score transformation to Affymetrix data. Appl Bioinformatics 2:209-17
Cho-Chung, Yoon S (2003) CRE-enhancer DNA decoy: a tumor target-based genetic tool. Ann N Y Acad Sci 1002:124-33
Mani, S; Goel, S; Nesterova, M et al. (2003) Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I. Ann N Y Acad Sci 1002:252-62
Cho-Chung, Yoon S; Becker, Kevin G (2003) A genome-wide view of antisense. Nat Biotechnol 21:492

Showing the most recent 10 out of 13 publications